TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $18,101,000 | -18.5% | 240,550 | -70.9% | 0.00% | -20.0% |
| Q1 2022 | $22,201,000 | -28.0% | 826,842 | +27.9% | 0.01% | -16.7% |
| Q4 2021 | $30,825,000 | +82.9% | 646,226 | +154.8% | 0.01% | +100.0% |
| Q3 2021 | $16,850,000 | +1330.4% | 253,648 | +1580.7% | 0.00% | – |
| Q2 2021 | $1,178,000 | -88.5% | 15,092 | -86.0% | 0.00% | -100.0% |
| Q1 2021 | $10,233,000 | +281.1% | 108,186 | +391.0% | 0.00% | – |
| Q4 2020 | $2,685,000 | -71.8% | 22,034 | -79.8% | 0.00% | -100.0% |
| Q3 2020 | $9,525,000 | +187.8% | 109,022 | +112.8% | 0.00% | +200.0% |
| Q2 2020 | $3,310,000 | +522.2% | 51,241 | +330.1% | 0.00% | – |
| Q1 2020 | $532,000 | -71.3% | 11,913 | -73.8% | 0.00% | -100.0% |
| Q2 2019 | $1,854,000 | – | 45,541 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |